A View LCS

by Coreline Soft Co.  · Based in South Korea → — AI-powered medical imaging for comprehensive thoracic disease diagnosis.
Cardiology Pulmonology Radiology

Contact for quote
Regulatory Status Disclosed

Overview

AVIEW LCS by Coreline Soft is an advanced artificial intelligence (AI) powered imaging platform designed for the comprehensive analysis of thoracic CT images. It specializes in lung disease screening, offering automated detection and quantification of pulmonary nodules, emphysema, and coronary artery calcification (CAC) from a single low-dose CT scan. The platform aims to enhance diagnostic accuracy, reduce interpretation time, and streamline clinical workflows for radiologists and other medical professionals.

The software provides detailed characterizations of lung nodules, including type, location, size (major axis, minor axis), estimated effective diameter, volume, and mean/min/max Hounsfield Units (HU). It also integrates Lung-RADS scoring to standardize lung cancer screening CT reporting and management recommendations. For emphysema, AVIEW LCS quantifies the low attenuation area (LAA) and generates an emphysema index. In terms of cardiac health, it automatically segments coronary arteries and calculates Agatston, volume, and mass scores for coronary artery calcification, providing crucial indicators for coronary artery disease.

AVIEW LCS is part of Coreline Soft’s broader AVIEW portfolio, which includes solutions for COPD, CAC, and Interstitial Lung Disease (ILD), often combined in AVIEW LCS Plus for multi-disease screening. The tool has demonstrated clinical efficacy, showing a lower likelihood of misidentifying nodules compared to human radiologists in studies. It supports integration into standard reading environments like PACS and RIS, and can generate comprehensive PDF reports.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automated lung nodule detection and classification
  • Nodule volume quantification and measurement (3D)
  • Lung-RADS scoring and reporting
  • Emphysema analysis and quantification (LAA)
  • Coronary Artery Calcium (CAC) scoring (Agatston, volume, mass)
  • Segmentation of major coronary arteries
  • Automated comprehensive report generation (PDF, DICOM PDF, SR)
  • CT kernel conversion AI technology
  • Integration with PACS/RIS
  • Follow-up support with automated nodule matching and comparison

Use Cases

  • Lung cancer screening programs
  • Early detection and diagnosis of lung diseases
  • Quantification and assessment of Chronic Obstructive Pulmonary Disease (COPD)
  • Coronary Artery Disease risk assessment
  • Monitoring and follow-up of lung nodules
  • Streamlining radiology workflow and reporting

What Physicians Need to Know

Coronary Artery Assessment
AVIEW CAC and AVIEW LCS Plus automatically segment four main coronary arteries (right coronary artery, left main coronary, left anterior descending, and left circumflex artery) to quantify calcified plaques. It provides Agatston, volume, and mass scores for the whole heart and each segmented artery.
Cardiac CT Analysis
The tool performs quantitative analysis of coronary artery calcification (CAC) using both dedicated cardiac CT scans and non-contrast/non-gated chest CT images, broadening its clinical application.
Heart Disease Risk Stratification
AVIEW CAC provides CAC risk based on age and gender, offering percentile-based risk categories according to established guidelines to assist in understanding cardiovascular risk.
AHA/ACC Guideline Alignment
The software's capabilities align with clinical recommendations for coronary artery calcium analysis, such as those from the Society of Thoracic Radiology, which recommends CAC analysis for patients over 40 using chest CT scans.
Cardiac Monitoring Integration
AVIEW CAC integrates with standard reading environments like Picture Archiving and Communication Systems (PACS) and Radiological Information Systems (RIS). It supports DICOM data transfer for seamless workflow within clinical settings.
Automated Workflow
The system offers an automated workflow for coronary artery calcification analysis, from image acquisition and data transmission to automatic report generation, optimizing work processes and saving time for healthcare professionals.
Physician Tip

For optimal utilization of Coreline Soft's AVIEW CAC and AVIEW LCS Plus, physicians should leverage the automated coronary artery calcification scoring for early cardiovascular risk assessment, especially in patients undergoing chest CT for other indications. Integrate the quantitative results and risk stratification into patient counseling and management plans, particularly for those over 40. While excellent for CAC, remember that these tools are primarily focused on CT analysis and do not provide ECG/EKG analysis, echocardiography AI features, or direct arrhythmia detection. Always correlate AI findings with the full clinical picture and other diagnostic modalities.

Coreline Soft's AVIEW CAC and AVIEW LCS Plus are designed for robust integration into existing radiology and hospital IT infrastructure. They support integration with standard PACS and RIS environments, facilitating seamless DICOM data exchange. Deployment options include cloud-based, hybrid, or local installations on dedicated hardware or virtualized environments. This flexibility allows for integration into diverse clinical workflows and IT setups, ensuring accessibility of the AI analysis results within the physician's preferred reading environment.

Details

Category Cardiology AI, Oncology AI, Radiology & Imaging AI
Pricing Contact for quote
DeploymentCloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

AVIEW LCS has received FDA 510(k) clearance (Class II) for the review, analysis, and reporting of thoracic CT images to characterize lung nodules. The upgraded AVIEW 2.0 platform also received 510(k) approval.

Integrations
EHR Not specified
Specialties Cardiology, Pulmonology, Radiology

What the Web Says

A View LCS by Coreline Soft is an AI-powered medical software designed for comprehensive thoracic CT analysis, primarily for lung cancer screening, emphysema quantification, and coronary artery calcification. It aims to improve the accuracy and efficiency of lung nodule assessment and offers various deployment options including cloud, hybrid, local dedicated hardware, and virtualized solutions. The software has extensive clinical validation, including adoption in national lung cancer screening programs and numerous peer-reviewed publications.

Overall: Positive

Strengths

  • Comprehensive '3-in-1' thoracic CT analysis (lung cancer screening, emphysema, coronary artery calcification) from a single low-dose CT scan.
  • Significant innovation with 'CT kernel conversion AI technology' and AI that evaluates AI analysis results.
  • Extensive clinical validation with adoption in 7 national lung cancer screening programs and over 290 peer-reviewed publications.
  • Flexible deployment options: cloud, hybrid, local dedicated hardware, and virtualized solutions.
  • Proven integration with all major PACS and RIS, and ISO 27001 certification for enterprise-level adoption and security.
  • Automated detection and measurement of lung nodules, calculation of malignancy risk, and support for follow-ups with nodule matching.

Limitations

  • Pricing information is not readily available and requires direct contact with the vendor, lacking transparency.
  • Less explicit focus on broader usability aspects compared to competitors that emphasize web-based workflows and multimodality.
  • Specific details regarding customer support channels or documentation portals were not readily available through web searches.
  • While it aims to reduce workload, some competitors directly quantify efficiency gains and emphasize seamless integration into daily radiology practice.
  • May be a more specialized offering compared to Coreline Soft's broader AVIEW platform, which includes additional features like ILD pattern analysis and extensive workflow automation.
  • No ratings yet on platforms like G2 or Capterra.

Based on reviews from: Medical AI Tools for Physicians, Radiology AI Companies - X-ray Interpreter, ResearchGate, HealthAidb u2014 Software, FDA

Last updated: 2026-07-18

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate A View LCS

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Coreline Soft
A View LCS by Coreline Soft Co., Ltd. is a medical software tool that helps clinicians review, analyze, and report on thoracic CT scans.
A View LCS is a medical software tool that assists clinicians in reviewing, analyzing, and reporting on thoracic CT scans, automatically detecting and measuring lung nodules, calculating malignancy risk, and supporting follow-ups.
2020-10
FDA
FDA 510(k) Decisions During October, 2020
A View LCS from Coreline Soft Co., Ltd. received 510(k) clearance from the FDA on October 28, 2020.
2020-10
PMC
Theranostics and artificial intelligence: new frontiers in personalized medicine
A View LCS by Coreline Soft Co., Ltd. is listed among FDA-approved AI-based radiological software systems in clinical oncology, with a 2020 approval for PI-RADS prostate density classification using mpMRI.
2024-03
accessdata.fda.gov
CARPL.AI Inc. March 27, 2024 Josh Baker Consultant OT Consulting Inc. 33781 Bayside Lane Dana Point, CA 92629 Re: K232891 - accessdata.fda.gov
CARPL.AI Inc. lists A View LCS (K201710) from Coreline Soft Co.,Ltd. as an FDA-cleared algorithm integrated into their platform for medical image management and processing.
2024-03
Medical AI Tools for Physicians
A View LCS vs ASSURE Wearable ECG - Medical AI Tools for Physicians
A View LCS by Coreline Soft Co. is an AI-powered tool for analyzing thoracic CT scans, providing insights into lung nodules, emphysema, and coronary artery calcification.
unknown
ResearchGate
The Lithuanian Lung Cancer Screening Model: Results of a Pilot Study - ResearchGate
The 'Aview LCS Plus' artificial intelligence software package from Coreline Europe GmbH was used to interpret all chest LDCT images in a Lithuanian lung cancer screening pilot study.
2025-06
ResearchGate
Harnessing artificial intelligence for theragnostic applications: Current landscape and future directions - ResearchGate
A View LCS by Coreline Soft Co., Ltd. is mentioned in a review article discussing the current landscape and future directions of artificial intelligence in theragnostic applications, specifically for analyzing CT images to identify lung nodules.
2025-02
ResearchGate
Computational healthcare: Present and future perspectives (Review) - ResearchGate
A View LCS from Coreline Soft Co., Ltd. is listed as a radiology diagnosis tool approved in 2020 in a review of computational healthcare.
unknown

Videos

Product demos, reviews, and walkthroughs for A View LCS.

View all on YouTube

Frequently Asked Questions

AVIEW LCS is designed to integrate with your PACS and EMR systems, providing AI-driven insights directly within your imaging review and patient management platforms. It offers automated nodule detection, classification according to Lung-RADS, 3D visualization, and generates comprehensive reports to streamline your workflow.
AVIEW LCS has received significant regulatory clearances, including FDA (US), CE Mark (Europe), and approvals from other international bodies. It is built with robust security protocols to ensure compliance with data privacy regulations like HIPAA and GDPR, safeguarding patient information through de-identification and encryption.
AVIEW LCS offers high sensitivity (97%) for nodule detection and can identify even small nodules, potentially reducing missed findings and radiologist workload. It provides quantitative analysis, including nodule volume, growth tracking, and Lung-RADS classification, which can enhance diagnostic accuracy and efficiency.
AVIEW LCS is a decision support tool intended to augment, not replace, physician judgment, and the ultimate diagnostic responsibility remains with the physician. While highly effective, human expert review remains crucial for complex cases, very subtle findings, or when interpreting results in patient populations not extensively represented in validation studies.
While specific pricing details are not publicly disclosed, AI solutions like AVIEW LCS typically operate on subscription-based models, which can be tailored to an institution's patient volume or usage. Providers should contact Coreline Soft or their distributors for detailed pricing structures and options suitable for their specific practice size or institutional requirements.
Yes, AVIEW LCS has undergone extensive clinical validation through multi-center trials, with results published in peer-reviewed articles. Studies have demonstrated its effectiveness in improving nodule detection rates, reducing false negatives, and significantly decreasing radiologist workload in lung cancer screening.
AVIEW LCS functions as a computer-aided detection (CAD) system, providing adjunctive information to assist radiologists, but the final diagnostic interpretation and decision-making responsibility rests with the physician. Its use is generally considered to fall under standard medical malpractice insurance when integrated appropriately as a decision support tool.

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

More from Coreline Soft

AVIEW
Coreline Soft Co.
Cardiology AI
Coreline Soft's AVIEW AI platform offers comprehensive solutions for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans, enhancing diagnostic precision and streamlining radiology workflows.
AVIEW CAC
Coreline Soft Co.
Cardiology AI
AI-powered software for automated coronary artery calcium analysis from CT scans, providing quantitative results and risk assessment to aid in early detection and management of coronary artery disease.
AVIEW LCS
Coreline Soft Co.
Cardiology AI
Coreline Soft's AVIEW LCS is an AI-powered solution for the detection and analysis of lung nodules. The AVIEW LCS Plus platform provides integrated, fully automatic analysis of lung cancer, COPD, and coronary artery calcification from a single low-dose CT scan, enhancing diagnostic accuracy and streamlining radiology workflows.
AVIEW Lung Nodule CAD
Coreline Soft Co.
Cardiology AI
AVIEW Lung Nodule CAD is an AI-powered software by Coreline Soft Co. that assists radiologists in detecting and analyzing pulmonary nodules on chest CT scans, and offers comprehensive screening for lung cancer, COPD, and coronary artery calcification.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.